inSoma Bio, Inc. — Form D

inSoma Bio, Inc. of DURHAM, NC, a company, filed a Form D exempt-offering notice with the SEC on 2025-10-20. The offering totals $3.0M, of which $1.9M was reported sold. Industry: Biotechnology.

Offering

Filed: 2025-10-20
Form: D
Accession: 0001814250-25-000002
Industry: Biotechnology
Exemptions: 06b
Total offering: $3.0M
Amount sold: $1.9M
Remaining: $1.1M
Investors: 8
Date of first sale: 2025-09-24
Revenue range: Decline to Disclose
SEC file number: 021-561358

Issuer

Name: inSoma Bio, Inc.
CIK: 0001814250
Entity type: Corporation
Jurisdiction: DELAWARE
Incorporated: 2018
Address: 701 W. MAIN STREET, SUITE 410, DURHAM, NC, 27701
Phone: 901 827 4757

Officers, directors & promoters (12)

Name	Role	Location
June S Almenoff	Director	Durham, NC
Juliana Blum	Director	Durham, NC
Heather Brennan	Director	Durham, NC
Ashutosh Chilkoti	Director	Durham, NC
Stefan Roberts	Director	Durham, NC
Ashutosh Chilkoti	Executive Officer	Durham, NC
Stefan Roberts	Executive Officer	Durham, NC
Juliana S Blum	Director	Durham, NC
Heather S Brennan	Director	Durham, NC
Stefan E Roberts	Director	Durham, NC
Stefan E Roberts	Executive Officer	Durham, NC
June S. Almenoff	Director	Durham, NC

Other filings by this issuer (11)

Filed	Form	Offering	Sold
2026-01-22	D/A	$4.0M	$2.7M
2024-05-06	D/A	$3.0M	$2.7M
2023-06-29	D/A	$3.0M	$2.1M
2023-05-01	D	$3.0M	$1.1M
2020-12-01	D/A	$1.5M	$1.3M
2020-11-09	D/A	$1.5M	$1.2M
2020-10-26	D/A	$1.0M	$385K
2020-10-13	D/A	$1.0M	$310K
2020-09-17	D/A	$1.0M	$110K
2020-09-03	D	$1.0M	$50K
2020-07-09	D	$202K	$202K

More